# SCH708980 With and Without AmBisome for Visceral Leishmaniasis

> **NCT01437020** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Leishmaniasis
- Effects of Immunotherapy

## Interventions

- **DRUG:** SCH708980 Anti-IL-10 monoclonal
- **DRUG:** AmBisome

## Key facts

- **NCT ID:** NCT01437020
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Drug Product no longer available.
- **Last updated:** 2013-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01437020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01437020, "SCH708980 With and Without AmBisome for Visceral Leishmaniasis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01437020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*